Alzheimer’s disease (AD), characterized by cognitive decline, is a neurodegenerative disorder and is associated with amyloid-β (Aβ) plaque deposition, neuronal loss, and hyperphosphorylation of tau protein. Here, MAPT is linked to Alzheimer disease.